Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL3 | Q96JM7 | 2/20 | 0.34 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL680295 | 0.91 | L3MBTL3 (0.38) | L3MBTL3L3MBTL1 | |
| SCHEMBL23761690 | 0.83 | PIM1 (0.34) | PIM1 | |
| SCHEMBL9883843 | 0.83 | PIM1 (0.34) | PIM1 | |
| SCHEMBL15882974 | 0.83 | PIM1 (0.34) | PIM1 | |
| SCHEMBL22166558 | 0.80 | L3MBTL3 (0.42) | L3MBTL3L3MBTL1 | |
| SCHEMBL8260570 | 0.78 | HRH4 (0.33) | L3MBTL3 | |
| SCHEMBL679560 | 0.78 | HRH4 (0.33) | L3MBTL3 | |
| SCHEMBL731310 | 0.78 | HRH4 (0.33) | L3MBTL3 | |
| SCHEMBL13791631 | 0.76 | — | — | |
| SCHEMBL24764256 | 0.76 | ROCK2 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159491-A1 | Antimicrobial Compounds and Methods | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-05-25 | — | — | US | disclosed |
| US-9969719-B2 | Substituted 2-hydrogen-pyrazole derivative serving as anticancer drug | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) | 2018-05-15 | — | — | US | disclosed |
| US-9969719-B2 | Substituted 2-hydrogen-pyrazole derivative serving as anticancer drug | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) | 2018-05-15 | — | — | US | disclosed |
| US-20180072707-A1 | SUBSTITUTED 2-HYDROGEN-PYRAZOLE DERIVATIVE SERVING AS ANTICANCER DRUG | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) | 2018-03-15 | — | — | US | disclosed |
| US-20180072707-A1 | SUBSTITUTED 2-HYDROGEN-PYRAZOLE DERIVATIVE SERVING AS ANTICANCER DRUG | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) | 2018-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180072707-A1 | SUBSTITUTED 2-HYDROGEN-PYRAZOLE DERIVATIVE SERVING AS ANTICANCER DRUG | CDK4, CDK6, CDK3 | L3MBTL3 3022/4885PIM1 158/4885L3MBTL1 3069/4885 |
| US-20230159491-A1 | Antimicrobial Compounds and Methods | MPO, NISCH, RPN2 | L3MBTL3 1338/4885PIM1 505/4885L3MBTL1 1507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.